Tag: bioquark
Pain Control in a Post-Opioid World — Prof. Peter McNaughton FMedSci — IdeaXme — Ira Pastor
Posted in aging, biotech/medical, business, chemistry, futurism, genetics, health, innovation, life extension, neuroscience | Leave a Comment on Pain Control in a Post-Opioid World — Prof. Peter McNaughton FMedSci — IdeaXme — Ira Pastor
Add 15 healthy years to the lives of 1 million people — YoLife.io — Tassilo Weber — Ira Pastor — IdeaXme
Posted in aging, biotech/medical, business, computing, DNA, genetics, health, life extension, science, transhumanism | Leave a Comment on Add 15 healthy years to the lives of 1 million people — YoLife.io — Tassilo Weber — Ira Pastor — IdeaXme
Dr. Dario Altieri, President, CEO, and Director of the Wistar Institute Cancer Center — Ira Pastor — IdeaXme
Posted in aging, biotech/medical, chemistry, DNA, genetics, health, life extension, posthumanism, science, transhumanism | Leave a Comment on Dr. Dario Altieri, President, CEO, and Director of the Wistar Institute Cancer Center — Ira Pastor — IdeaXme
Dr. Gerald Pollack — Water, and the Hydro-Dynamic aspects of Life, Health and Aging — Ira Pastor — IdeaXme
Posted in aging, biological, biotech/medical, cryonics, disruptive technology, DNA, futurism, health, life extension, science | Leave a Comment on Dr. Gerald Pollack — Water, and the Hydro-Dynamic aspects of Life, Health and Aging — Ira Pastor — IdeaXme
Fighting Aging With Stress, Randomness, Complexity and Usefulness — Dr. Marios Kyriazis — Ira Pastor
Posted in aging, bioengineering, biological, bioprinting, biotech/medical, cosmology, DNA, evolution, genetics, health | Leave a Comment on Fighting Aging With Stress, Randomness, Complexity and Usefulness — Dr. Marios Kyriazis — Ira Pastor
Studying evolution to banish ageing — a new frontier in gerontological drug development
Posted in aging, bioengineering, biological, biotech/medical, DNA, evolution, futurism, genetics, health, life extension | Leave a Comment on Studying evolution to banish ageing — a new frontier in gerontological drug development